ebook Munafa Stock Market Course + Intraday & FNO calls  

       

CRNX announcements Crinetics Pharmaceuticals, Inc. announcements and dividends declared USA

Crinetics Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Crinetics Pharmaceuticals, Inc. CRNX

Crinetics Pharmaceuticals, Inc. CRNX listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Crinetics Pharmaceuticals, Inc. CRNX

Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
Crinetics Pharmaceuticals, Inc. (CRNX) shares ended the last trading session 19.1% higher at .18. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to
Announcement as on 20 March 2024

Crinetics Pharmaceuticals (FRA:6Z4) Price Target Increased by 11.73% to 48.98
The average one-year price target for Crinetics Pharmaceuticals (FRA:6Z4) has been revised to 48.98 / share. This is an increase of 11.73% from the prior estimate of 43.84 dated August 31, 2023. The price target is an average of many targets provided by a
Announcement as on 06 October 2023

: Crinetics Pharmaceuticals shares surge 65%, analysts raise price target after acromegaly treatment results
Shares of Crinetics Pharmaceuticals Inc. CRNX gained 65% premarket on Monday after the company announced positive results from a late-stage study of paltusotine, its investigational treatment for acromegaly. The phase 3 trial met the primary endpoint and a
Announcement as on 11 September 2023

: Crinetics Pharmaceuticals shares rise as analysts see ‘drug hunters in their zone’
Shares of Crinetics Pharmaceuticals Inc. CRNX gained more than 4% premarket on Thursday after Oppenheimer analysts initiated coverage of the shares with an outperform rating, calling Crinetics ‘drug hunters in their zone.’ Crinetics focuses on developi
Announcement as on 31 August 2023

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) came out with a quarterly loss of [CO].85 per share versus the Zacks Consensus Estimate of a loss of [CO].82. This compares to loss of [CO].73 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 04 May 2023

Announcements by Crinetics Pharmaceuticals, Inc. first page | Next page |

CRNX Crinetics Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Crinetics Pharmaceuticals, Inc.

  • 5Day Average: 50.78
  • 12Day Average: 48.97
  • 20Day Average: 48.77
  • 50Day Average: 45.95
  • 100Day Average: 41.79
  • 150Day Average: 37.99
  • 200Day Average: 36.22

CRNX Indicators & signals

Indicator MACD (12,26,9)

49.68, 48.23, 1.01
Indicator MACD is in positive zone

Indicator ADX (14)

41.76, 42.02, 17.26
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of CRNX Crinetics Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Fri Jan 2026 53.25 53.17 to 56.13 0.15% 1.33 times
08 Thu Jan 2026 53.17 51.50 to 54.54 -0.32% 0.63 times
07 Wed Jan 2026 53.34 49.72 to 53.97 16.08% 2.92 times
06 Tue Jan 2026 45.95 43.40 to 48.56 -4.63% 1.48 times
05 Mon Jan 2026 48.18 46.86 to 57.99 3.1% 2.77 times
02 Fri Jan 2026 46.73 45.51 to 47.05 0.39% 0.45 times
31 Wed Dec 2025 46.55 46.43 to 47.35 -1.77% 0.38 times
30 Tue Dec 2025 47.39 47.04 to 48.25 -0.27% 0.36 times
29 Mon Dec 2025 47.52 47.12 to 48.24 -0.92% 0.58 times
26 Fri Dec 2025 47.96 47.80 to 48.41 -1.54% 0.25 times
24 Wed Dec 2025 48.71 48.52 to 49.61 -0.33% 0.18 times
23 Tue Dec 2025 48.87 48.61 to 49.40 -0.75% 0.65 times

Videos related to: CRNX announcements Crinetics Pharmaceuticals, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

CRNX announcements Crinetics Pharmaceuticals, Inc. announcements and dividends declared USA

 

Back to top